0000899243-21-000430.txt : 20210105 0000899243-21-000430.hdr.sgml : 20210105 20210105174046 ACCESSION NUMBER: 0000899243-21-000430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210105 DATE AS OF CHANGE: 20210105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burrell Terry-Ann CENTRAL INDEX KEY: 0001786484 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39208 FILM NUMBER: 21507440 MAIL ADDRESS: STREET 1: C/O BEAM THERAPEUTICS INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beam Therapeutics Inc. CENTRAL INDEX KEY: 0001745999 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-327-8775 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001745999 Beam Therapeutics Inc. BEAM 0001786484 Burrell Terry-Ann C/O BEAM THERAPEUTICS INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 0 1 0 0 CFO Common Stock 2021-01-04 4 M 0 25000 13.68 A 32309 D Common Stock 2021-01-04 4 S 0 800 78.05 D 31509 D Common Stock 2021-01-04 4 S 0 1951 79.21 D 29558 D Common Stock 2021-01-04 4 S 0 2449 80.25 D 27109 D Common Stock 2021-01-04 4 S 0 6509 81.26 D 20600 D Common Stock 2021-01-04 4 S 0 5296 82.44 D 15304 D Common Stock 2021-01-04 4 S 0 7095 83.15 D 8209 D Common Stock 2021-01-04 4 S 0 900 83.89 D 7309 D Stock Option (Right to Buy) 13.68 2021-01-04 4 M 0 25000 0.00 D 2029-08-31 Common Stock 25000 357941 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Each price reported for transactions affected pursuant to the Rule 10b5-1 trading plan is a weighted average price. The Reporting Person undertakes to provide to BEAM, any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 25% of the shares subject to the stock option vested on the first anniversary of the of the vesting commencement date, August 20, 2019, and the remaining shares shall vest in 36 substantially equal monthly installments thereafter, subject to continued service with BEAM through such dates. These shares were sold in multiple transactions ranging from $77.65 to $78.48 inclusive. These shares were sold in multiple transactions ranging from $78.72 to $79.65 inclusive. These shares were sold in multiple transactions ranging from $79.73 to $80.72 inclusive. These shares were sold in multiple transactions ranging from $80.73 to $81.72 inclusive. These shares were sold in multiple transactions ranging from $81.80 to $82.79 inclusive. These shares were sold in multiple transactions ranging from $82.80 to $83.78 inclusive. These shares were sold in multiple transactions ranging from $83.85 to $84.01 inclusive. By: /s/ Christine Bellon, Attorney-in-fact 2021-01-05